Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

被引:24
作者
Huff-Hardy, Kayci [1 ]
Bedair, Mai [2 ]
Vazquez, Rebecca [2 ]
Burstein, Ezra [1 ]
机构
[1] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA
关键词
MAINTENANCE THERAPY; INDUCTION;
D O I
10.1097/MIB.0000000000001232
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:E49 / E49
页数:1
相关论文
共 50 条
  • [31] Vedolizumab in the treatment of Crohn's disease
    Gisbert, Javier P.
    Domenech, Eugeni
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2015, 38 (05): : 338 - 348
  • [32] Vedolizumab for the treatment of Crohn's disease
    Argollo, Marjorie
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (03) : 179 - 189
  • [33] The safety of vedolizumab for ulcerative colitis and Crohn's disease
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Rutgeerts, Paul
    Sandborn, William
    Danese, Silvio
    D'Haens, Geert
    Panaccione, Remo
    Loftus, Edward V., Jr.
    Sankoh, Serap
    Fox, Irving
    Parikh, Asit
    Milch, Catherine
    Abhyankar, Brihad
    Feagan, Brian G.
    GUT, 2017, 66 (05) : 839 - 851
  • [34] Vedolizumab for the treatment of ulcerative colitis and Crohn's disease
    McLean, Leon P.
    Shea-Donohue, Terez
    Cross, Raymond K.
    IMMUNOTHERAPY, 2012, 4 (09) : 883 - 898
  • [35] Ustekinumab to treat Crohn's disease
    Gisbert, Javier P.
    Chaparro, Maria
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (10): : 688 - 698
  • [36] Ustekinumab for the treatment of Crohn's disease
    Khanna, Reena
    Feagan, Brian G.
    IMMUNOTHERAPY, 2013, 5 (08) : 803 - 815
  • [37] Ustekinumab for the treatment of Crohn's disease
    Hansen, Tawnya
    Targownik, Laura E.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (09) : 989 - 994
  • [38] Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy
    Scribano, Maria Lia
    Aratari, Annalisa
    Neri, Benedetto
    Bezzio, Cristina
    Balestrieri, Paola
    Baccolini, Valentina
    Falasco, Giuliano
    Camastra, Caterina
    Pantanella, Paolo
    Monterubbianesi, Rita
    Tullio, Alessandro
    Saibeni, Simone
    Papi, Claudio
    Biancone, Livia
    Cosintino, Rocco
    Faggiani, Roberto
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [39] Comparison of surgery rates in biologic-naive patients with Crohn's disease treated with vedolizumab or ustekinumab: findings from SOJOURN
    Vu, Michelle
    Ghosh, Sabyasachi
    Umashankar, Kandavadivu
    Weber, Laura
    Landis, Christina
    Candela, Ninfa
    Chastek, Benjamin
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [40] Ustekinumab: A Review in Moderate to Severe Crohn's Disease
    Lamb, Yvette N.
    Duggan, Sean T.
    DRUGS, 2017, 77 (10) : 1105 - 1114